Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Butterfly Network, Inc.
BFLY
NYSE·Healthcare·Medical - Devices·Mkt cap $2.1B
$7.44
▼ -6.18%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$1.32 - $9.69
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 304.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary single-probe whole-body ultrasound technology enabling portability and ease-of-use
- Smartphone and tablet integration reducing capital expenditure and expanding addressable market
- Integrated software ecosystem (Compass, Blueprint) creating healthcare system lock-in and recurring revenue
- Established direct sales force and multi-channel distribution strategy
- Clinical education platform (Butterfly Academy) building user loyalty and expanding adoption
Bear Case
1 risk
- High volatility (beta 2.2). Larger-than-normal price swings expected.
Growth
Stable outlook
Expansion of point-of-care ultrasound adoption in emergency departments, primary care, and rural healthcare
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+92.9% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying BFLY right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Jul 31, 2026
APR 30, 2026
Reported EPS of -$0.03 vs -$0.04 consensus (+25.0% surprise). Revenue of $26.5M vs $26.1M expected (+1.7%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+25.0%
Next: Jul 31, 2026
Revenue trend · last 8Q
—
—
+35%
+20%
+9%
+5%
+41%
+25%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$21.5M
$20.6M
$22.4M
$21.2M
$23.4M
$21.5M
$31.5M
$26.5M
Margins · last 8Q
Gross
—
Operating
—
Profit
-47.8%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Freedom Broker · Mar 2, 2026